EoGenius™ Test for Eosinophilic Esophagitis Launched by Miraca Life Sciences
Marc Rothenberg, MD, PhD, developed a test called EoGenius to help diagnose and monitor patients with eosinophilic esophagitis (EoE). The EoGenius test uses tissue from a biopsy and provides a positive, negative, or indeterminate result based on the gene expression score produced by the test’s algorithm.
EoE can be difficult to diagnose with the average patient experiencing a six year diagnostic delay. The EoGenius test makes diagnosing EoE easier so patients can receive appropriate treatment.
Read more at MiracleLifeSciences.com.